Thus, agents targeting CD47 may bind to erythrocytes or platelets and the subsequent phagocytosis could induce hematologic toxicity such as hemolytic anemia and thrombocytopenia (28, 29). The gene discussed is CD47; the disease is Thrombocytopenia.